AbsEn.i
Analysis
an2020
Racine
Analysis
an2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration Covid (26 mars) - Analysis (an2020)

Index « AbsEn.i » - entrée « trials »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
trial < trials < triangle  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 17.
Ident.Authors (with country if any)Title
000048 (2020) H. Li [République populaire de Chine] ; Y M Wang [République populaire de Chine] ; J Y Xu [République populaire de Chine] ; B. Cao [République populaire de Chine][Potential antiviral therapeutics for 2019 Novel Coronavirus].
000181 (2020) Haiou Li [République populaire de Chine] ; Yunjiao Zhou [République populaire de Chine] ; Meng Zhang [République populaire de Chine] ; Haizhou Wang [République populaire de Chine] ; Qiu Zhao [République populaire de Chine] ; Jing Liu [République populaire de Chine]Updated approaches against SARS-CoV-2.
000196 (2020) Andre C. Kalil [États-Unis]Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.
000220 (2020) Robert L. Kruse [États-Unis]Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China.
000420 (2020) Ken J. Goh [Singapour] ; Mindy Cm Choong ; Elizabeth Ht Cheong ; Shirin Kalimuddin ; Sewa Duu Wen ; Ghee Chee Phua ; Kian Sing Chan ; Salahudeen Haja MohideenRapid Progression to Acute Respiratory Distress Syndrome: Review of Current Understanding of Critical Illness from COVID-19 Infection.
000486 (2020) David A. Schwartz [États-Unis] ; Ashley L. GrahamPotential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections
000556 (2020) Christian A. Devaux [France] ; Jean-Marc Rolain [France] ; Philippe Colson [France] ; Didier Raoult [France]New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
000705 (2020) David S. Fedson [Oman] ; Steven M. Opal [États-Unis] ; Ole Martin Rordam [Norvège]Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection.
000748 (2020) Atte Sandelin [Finlande] ; Heidi H Rtel ; Leena Sepp Lassila [Finlande] ; Liisa Kaartinen [Finlande] ; Helena Rautala [Finlande] ; Timo Soveri [Finlande] ; Heli Simojoki [Finlande]Field trial to evaluate the effect of an intranasal respiratory vaccine protocol on bovine respiratory disease incidence and growth in a commercial calf rearing unit
000809 (2020) Youlin Long [République populaire de Chine] ; Tengyue Hu [République populaire de Chine] ; Liqin Liu [République populaire de Chine] ; Rui Chen [République populaire de Chine] ; Qiong Guo [République populaire de Chine] ; Liu Yang [République populaire de Chine] ; Yifan Cheng [République populaire de Chine] ; Jin Huang [République populaire de Chine] ; Liang Du [République populaire de Chine]Effectiveness of N95 respirators versus surgical masks against influenza: A systematic review and meta-analysis.
000979 (2020) Miguel Angel Martinez [Espagne]Compounds with therapeutic potential against novel respiratory 2019 coronavirus.
000987 (2020) Li Ni [République populaire de Chine] ; Ling Zhou [République populaire de Chine] ; Min Zhou [République populaire de Chine] ; Jianping Zhao [République populaire de Chine] ; Dao Wen Wang [République populaire de Chine]Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19 in Wuhan
000993 (2020) Jacqui Thornton [Royaume-Uni]Clinical trials suspended in UK to prioritise covid-19 studies and free up staff.
000994 (2020) Tengyue Zhang [République populaire de Chine] ; Yudi He [République populaire de Chine] ; Wenshuai Xu [République populaire de Chine] ; Aiping Ma [République populaire de Chine] ; Yanli Yang [République populaire de Chine] ; Kai-Feng Xu [République populaire de Chine]Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need
000B03 (2020) Dan Zhou [République populaire de Chine] ; Sheng-Ming Dai [République populaire de Chine] ; Qiang Tong [République populaire de Chine]COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression.
000B95 (2020) Jianjun Gao [République populaire de Chine] ; Zhenxue Tian [République populaire de Chine] ; Xu Yang [République populaire de Chine]Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.
000C11 (2020) Chih-Cheng Lai [Taïwan] ; Yen Hung Liu [Taïwan] ; Cheng-Yi Wang [Taïwan] ; Ya-Hui Wang [Taïwan] ; Shun-Chung Hsueh [Taïwan] ; Muh-Yen Yen [Taïwan] ; Wen-Chien Ko [Taïwan] ; Po-Ren Hsueh [Taïwan]Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/an2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/an2020/Analysis/AbsEn.i -k "trials" 

HfdIndexSelect -h $EXPLOR_AREA/Data/an2020/Analysis/AbsEn.i  \
                -Sk "trials" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/an2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    an2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    trials
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021